{"contentid": 488551, "importid": NaN, "name": "Coronavirus vaccine approved for use in children", "introduction": "Health Canada has approved a broader use of Comirnaty, the coronavirus vaccine from BioNTech and Pfizer, to include 12 to 15 year olds.", "content": "<p><span style=\"font-weight: 400;\">Health Canada has approved a broader use of Comirnaty, the coronavirus vaccine from BioNTech (Nasdaq: BNTX) and Pfizer (NYSE: PFE), to include 12 to 15 year olds.</span></p>\n<p><span style=\"font-weight: 400;\">The decision from the Canadian medicines regulator marks a key milestone for the use of vaccines against COVID-19, at a time when rates of infection continue to rise globally.</span></p>\n<p><span style=\"font-weight: 400;\">The US Food and Drug Administration is also expected to provide a decision on broadening the label for Comirnaty this week, with the firm providing supportive data from a Phase III trial enrolling 2,260 adolescents.</span></p>\n<p><span style=\"font-weight: 400;\">All participants in the trial will continue to be monitored for long-term protection and safety for an additional two years after their second dose.</span></p>\n<h2><strong>Vaccination efforts</strong></h2>\n<p><span style=\"font-weight: 400;\">While demand for vaccines continues to outstrip supplies in many parts of the world, certain countries have been able to cover a large percentage of their populations in recent months.</span></p>\n<p><span style=\"font-weight: 400;\">In the UK, USA and elsewhere, attention is turning towards vaccinating younger groups and those who have not previously been engaged with the vaccination process.</span></p>\n<p><span style=\"font-weight: 400;\">The first approval in this demographic represents an important objective for vaccine developers, demonstrating that the technology can be used safely and effectively in children, just as more schools reopen their gates.</span></p>\n<p><span style=\"font-weight: 400;\">Preventing transmission of the virus in educational settings could be key to slowing the virus down within society at large.</span></p>\n<p><span style=\"font-weight: 400;\">With this in mind, multiple developers have been testing coronavirus vaccines in children, including Moderna (Nasdaq: MRNA), which has been running a trial in children over 12.</span></p>\n<p><span style=\"font-weight: 400;\">Pfizer and BioNTech are also studying Comirnaty in children aged six to 12, while AstraZeneca (LSE: AZN) has a UK-based pediatric trial of its option, Vaxzevria, </span><a href=\"https://www.thepharmaletter.com/article/oxford-pauses-pediatric-trial-of-astrazeneca-vaccine\"><span style=\"font-weight: 400;\">currently on hold</span></a><span style=\"font-weight: 400;\">.</span></p>\n<p><span style=\"font-weight: 400;\">Commenting on the Canadian regulatory decision, BioNTech chief medical officer &Ouml;zlem T&uuml;reci said his firm had been &ldquo;working tirelessly to get our COVID-19 vaccine authorized around the world in order to provide access to as many countries as possible.&rdquo;</span></p>\n<p><span style=\"font-weight: 400;\">He added: &ldquo;I am proud of today&rsquo;s expanded authorization of our COVID-19 vaccine, making it available for use in adolescents. Our work is not yet complete, as we continue our research into the use of our vaccine in pediatric populations.&rdquo;</span></p>", "date": "2021-05-06 10:25:00", "meta_title": NaN, "meta_keywords": "vaccine, children, coronavirus, BioNTech, approved, trial, Comirnarty, Pfizer, decision, continue, COVID-, Canada, broader, Health, include, year, olds", "meta_description": "Health Canada has approved a broader use of Comirnarty, the coronavirus vaccine from BioNTech and Pfizer, to include 12 to 15 year olds.", "meta_robots": NaN, "meta_display_in_sitemap": 1, "canonical_url": NaN, "status": 3, "access_status": 0, "ignore_flexible_sampling": 0, "display_start_date": "0000-00-00 00:00:00", "display_end_date": "0000-00-00 00:00:00", "display_in_search": 1, "created": "2021-05-06 09:57:14", "updated": "2021-05-06 10:26:19", "access": NaN, "url": "https://www.thepharmaletter.com/article/coronavirus-vaccine-approved-for-use-in-children", "description": NaN, "twitter_term": NaN, "twitter_widgetid": NaN, "key_facts": NaN, "news_snippet": NaN, "image1id": "canada_big.jpg", "image2id": "canada_small.jpg", "restrict_print": 0, "restrict_print_for_logged_out": 0, "box1_header": NaN, "box1_title": NaN, "box1_image1id": 0, "box1_url": NaN, "box1_introduction": NaN, "box1_position": 0, "tags": NaN, "sector_tag": "Biotechnology", "therapy area_tag": "Infectious diseases, Vaccines", "topic_tag": "Coronavirus, Drug Trial, Focus On, Public health, Regulation, Research", "geography_tag": "Canada, Germany, USA", "company_tag": "BioNTech, Pfizer", "drug_tag": "Comirnaty", "market index_tag": NaN, "theme_tag": NaN, "industry sector_tag": NaN, "medical condition_tag": NaN, "industry term_tag": NaN, "organization_tag": NaN, "person_tag": NaN, "position_tag": NaN, "medical treatment_tag": NaN, "facility_tag": NaN, "technology_tag": NaN, "journalist_tag": NaN, "published medium_tag": NaN, "political event_tag": NaN, "anniversary_tag": NaN, "sports event_tag": NaN, "movie_tag": NaN, "fax number_tag": NaN, "currency pair_tag": NaN, "sports league_tag": NaN, "date_tag": NaN, "music group_tag": NaN, "phone number_tag": NaN, "t v show_tag": NaN, "t v station_tag": NaN, "entertainment award event_tag": NaN, "industry_tag": NaN, "pharmaceutical drug_tag": NaN, "topmost public parent company_tag": NaN, "content_type_name": "Article", "pubDate": "2021-05-06 10:25:00"}